USE OF TWO BLOOD-BASED BIOMARKER TESTS IN SERIES TO RECLASSIFY RISK OF INDETERMINATE PULMONARY NODULES

被引：0
|
作者：
Pitcher, Trevor
Jett, James
Springmeyer, Steven
Doubleday, Kevin
Peek, Laura
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1331
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1476A / 1477A
页数：2
相关论文
共 50 条
  • [31] The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules
    Tahvilian, Shahram
    Kuban, Joshua D.
    Yankelevitz, David F.
    Leventon, Daniel
    Henschke, Claudia I.
    Zhu, Jeffrey
    Baden, Lara
    Yip, Rowena
    Hirsch, Fred R.
    Reed, Rebecca
    Brown, Ashley
    Muldoon, Allison
    Trejo, Michael
    Katchman, Benjamin A.
    Donovan, Michael J.
    Pagano, Paul C.
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [32] ECONOMIC IMPACT MODEL TO ESTIMATE THE VALUE OF BLOOD-BASED BIOMARKERS IN THE RISK ASSESSMENT OF PULMONARY NODULES (PNS) FROM A HEALTH SYSTEM PERSPECTIVE
    O'day, K.
    Li, Q.
    Dupont, T.
    Iranitalab, R.
    Le, K.
    VALUE IN HEALTH, 2024, 27 (12)
  • [33] A blood-based biomarker panel to risk-stratify mild traumatic brain injury
    Sharma, Richa
    Rosenberg, Alexandra
    Bennett, Ellen R.
    Laskowitz, Daniel T.
    Acheson, Shawn K.
    PLOS ONE, 2017, 12 (03):
  • [34] A blood-based lipid biomarker panel for personalized risk assessment of breast cancer.
    Fahrmann, Johannes F.
    Irajizad, Ehsan
    Vykoukal, Jody
    Barrera, Angelica Gutierrez
    Dennison, Jennifer B.
    Wu, Ranran
    Arun, Banu
    Brewster, Abenaa
    Hanash, Samir
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [35] A novel blood-based biomarker for OAC with the potential for use as an early treatment response predictor
    Lawrence, Rachel
    Swithenbank, Lucy
    Haboubi, Hasan
    Williams, Lisa
    Gwynne, Sarah
    Doak, Shareen
    Jenkins, Gareth
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 30 - 31
  • [36] Use of a Blood-Based Proteomics Classifier for Pulmonary Nodule Risk Assessment Prior to Transcatheter Aortic Valve Replacement
    Bernstein, M. A.
    Kasov, C.
    Goff, I.
    Hastrup, F. C.
    Fallahi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [37] Validation of a High-Specificity Blood-Based Autoantibody Test to Detect Lung Cancer in Pulmonary Nodules
    Pitcher, T.
    Kammer, M.
    Nair, V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E25 - E25
  • [38] Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease
    Moll, Matthew
    Boueiz, Adel
    Ghosh, Auyon J.
    Saferali, Aabida
    Lee, Sool
    Xu, Zhonghui
    Yun, Jeong H.
    Hobbs, Brian D.
    Hersh, Craig P.
    Sin, Don D.
    Tal-Singer, Ruth
    Silverman, Edwin K.
    Cho, Michael H.
    Castaldi, Peter J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 161 - +
  • [39] Development of a Blood-Based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease
    Moll, M.
    El Boueiz, A. R.
    Ghosh, A. J.
    Saferali, A.
    Lee, S.
    Xu, Z.
    Yun, J. H.
    Hobbs, B. D.
    Hersh, C. P.
    Silverman, E. K.
    Cho, M. H.
    Castaldi, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [40] A Blood-Based Multi-Gene Expression Classifier to Distinguish Benign From Malignant Pulmonary Nodules
    Vachani, Anil
    Atalay, Michael
    Bremner, Ross
    Broussard, Brad
    Copeland, Karen
    Egressy, Katarine
    Ferguson, J.
    Friedman, Lyssa
    Harris, Randall
    Leach, Joseph
    McQuary, Philip
    O'Brien, Thomas
    Sarkar, Saiyad
    Sheibani, Nadia
    Shuff, Jaime
    Siler, Thomas
    Southwell, Clyde
    Hesterberg, Lyndal
    CHEST, 2017, 152 (04) : 629A - 630A
12345